Powered by:

 



Primer Simposio Imternacional sobre el uso de la Gonadotrofina Coriónica en la obesidad



Nueva Sección


Universidad Católica Argentina

Curso de Posgrado 
en 
Psicoterapia Simbólica
 
(nueva Ventana)





El uso de la Gonadotrofina Coriónica Humana (hCG) por vía oral para el tratamiento de la obesidad: Un estudio a Doble Ciego

Referencias

 

1. Albrink MJ. Chorionic gonadotropin and obesity?. Am J Clin Nutr 1969 Jun;22(6):681-5

2. ASCHEIM S; ZONDEK B. Die Shwangerschafts Diagnose aus dem Harn durch nachweis der Hypophysovorderlappenhormone. Klin. Wochschr. 7:1401-1411. 1928
3. Asher WL. Harper HW. Effect of human chorionic gonadotrophin on weight loss. hunger. and feeling of well-being. Am J Clin Nutr 1973 Feb;26(2):211-8
4. Astrup A.. VLCD compliance and lean body mass. Int J Obes 1989;13 Suppl 2:27-31
5. Atkinson JH. et al.. Plasma measures of beta-endorphin/beta-lipotropin-like immunoreactivity in chronic pain syndrome and psychiatric subjects. Psychiatry Res. 1983 Aug;9(4):319-27
6. Bagshawe KD. et al.. Pregnancy beta1 glycoprotein and chorionic gonadotrophin in the serum of patients with trophoblastic and non-trophoblastic tumors. Eur J Cancer. 1978 Dec;14(12):1331-5
7. Balducci R. et al.. Effect of hCG or hCG+ treatments in young thalassemic patients with hypogonadotropic hypogonadism. J Endocrinol Invest. 1990 Jan;13(1):1-7
8. Ballin JC. White PL. Fallacy and hazard. Human chorionic gonadotropin-500-calorie diet and weight reduction. JAMA 1974 Nov 4;230(5):693-4
9. Bastow MD. Anthropometrics revisited. Proc Nutr Soc 1982 Sep;41(3):381-8
10. Berry JN. Use of skinfold thickness for estimation of body fat. Indian J Med Res 1974 Feb;62(2):233-9
11. Birken S. et al.. Isolation and amino acid sequence of COOH-terminal fragments from the beta subunit of human choriogonadotropin. J Biol Chem. 1977 Aug 10;252(15):5386-92
12. Birken S.. Chemistry of human choriogonadotropin. Ann Endocrinol (Paris). 1984;45(4-5):297-305
13. Birmingham CL. et al.. Human chorionic gonadotropin is of no value in the management of obesity. Can Med Assoc J. 1983 May 15;128(10):1156-7
14. Bonandrini L. et al.. Chorionic gonadotropin (HCG) in the therapy of chronic peripheral obliterating arteriopathy (CPOA) of the lower extremities caused by arteriosclerosis. Minerva Chir. 1970 Mar 15;25(5):368-83
15. Borkan GA et al.. Comparison of ultrasound and skinfold measurements in assessment of subcutaneous and total fatness. Am J Phys Anthropol 1982 Jul;58(3):307-13
16. Borkan GA, Hults DE, Gerzof SG, Burrows BA, Robbins AH.Relationships between computed tomography tissue areas, thicknesses and total body composition. Ann Hum Biol. 1983 Nov-Dec;10(6):537-45.
17. Bosch B. et al.. Human chorionic gonadotrophin and weight loss. A double-blind. placebo-controlled trial. S Afr Med J 1990 Feb 17;77(4):185-9
18. Bousfield GR. et al.. Structural features of mammalian gonadotropins. Mol Cell Endocrinol. 1996 Dec 20;125(1-2):3-19
19. Bozzola M. et al.. Effect of human chorionic gonadotropin on growth velocity and biological growth parameters in adolescents with thalassemia major. Eur J Pediatr. 1989 Jan;148(4):300-3
20. Bradley P. Human chorionic gonadotrophin [letter]. Med J Aust Sep 25;2(13):510-1 1976
21. Brambilla F. et al.. beta-Endorphin and beta-lipotropin plasma levels in chronic schizophrenia. primary affective disorders and secondary affective disorders. Psychoneuroendocrinology. 1981 Dec;6(4):321-30
22. Bujanow W. Hormones in the treatment of psychoses. Br Med J Nov 4;4(835):298 1972
23. Bujanow W.Letter: Is oxytocin an anti-schizophrenic hormone?
Can Psychiatr Assoc J. 1974 Jun;19(3):323. No abstract available.
24. Cairella M.. Drug therapy of obesity. Clin Ter. 1978 Mar 31;84(6):571-92
25. Canfield RE. et al.. Studies of human chorionic gonadotropin. Recent Prog Horm Res. 1971;27:121-64
26. Cole LA.. Immunoassay of human chorionic gonadotropin. Its free subunit and metabolites. Clin Chem. 1997 Dec;43(12):2233-43
27. Emrich HM. Endorphins in psychiatry. Psychiatr Dev 1984 Summer;2(2):97-114
28. Ferrari C.. Use of a testosterone-gonadotropin combination in the treatment of pathological syndromes in adult males. Minerva Med. 1972 Jun 2;63(42):2399-408
29. Fiddes JC. et al.. Structure. expression. and evolution of the genes for the human glycoprotein hormones. Recent Prog Horm Res. 1984;40:43-78
30. Fiddes JC. et al.. The gene encoding the common alpha subunit of the four human glycoprotein hormones. J Mol Appl Genet. 1981;1(1):3-18
31. Fleigelman R. Metabolic effects of human chorionic gonadotropin (HCG) in rats. Proc Soc Exp Biol Med 1970 Nov;135(2):317-9
32. Gailani S. et al.. Human chorionic gonadotrophins (hCG) in non-trophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms. Cancer. 1976 Oct;38(4):1684-6
33. Gallo RC. Bryant J. Antitumor effects of hCG in KS. Nat Biotechnol Mar;16(3):218 1998
34. Giudice LC. et al.. Glycoprotein hormones: some aspects of studies of secondary and tertiary structure. Monograph. 1979 May 23
35. Greenway FL. et al.. Human chorionic gonadotropin (HCG) in the treatment of obesity: a critical assessment of the Simeons method. West J Med 1977 Dec;127(6):461-3
36. Grzonkowski S. Analysis of the results of the measurements of adipose tissue in the human body based on the study of skinfold thickness. Przegl Epidemiol 1989;43(3):272-82
37. Gusman HA. Chorionic gonadotropin in obesity. Further clinical observations. Am J Clin Nutr 1969 Jun;22(6):686-95
38. Hashimoto TK. Chorionic gonadotropin preparation as an analgesic. Arch Intern Med 1981 Feb;141(2):269
39. Hayes PA. Sub-cutaneous fat thickness measured by magnetic resonance imaging, ultrasound , and calipers. Med Sci Sports Exerc 1988 Jun;20(3):303-9
40. Weiss LW, Clark FC.Three protocols for measuring subcutaneous fat thickness on the upper extremities.http://Eur J Appl Physiol. 1987;56(2):217-21.
41. Heitmann BL et al. Evaluation of body fat estimated from body mass index, skinfolds and impedance. A comparative study. Eur J Clin Nutr 1990 Nov;44(11):831-7
42. Hermans P. Clumeck N. Picard O. et. Al.. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations. J Hum Virol Jan-Feb;1(2):82-9. 1998
43. LaPorte DJ. Predicting attrition and adherence to a very low calorie diet: a prospective investigation of the eating inventory. Int J Obes 1990 Mar;14(3):197-206
44. LaPorte DJ. Treatment response in obese binge eaters: preliminary results using a very low calorie diet (VLCD) and behavior therapy. Addict Behav 1992;17(3):247-57
45. Leshem Y. et al.. Gonadotropin promotion of adventitious root production on cuttings of Begonia semperflorens and Vitis vinifera. Plant Physiol. 1968 Mar;43(3):313-7
46. Lustbader JW. et al.. Structural and molecular studies of human chorionic gonadotropin and its receptor. Recent Prog Horm Res. 1998;53:395-424
47. Malkin A. The presence of glycosilated, biologically active chorionic gonadotropin in human liver. Clin Biochem 1985 Apr;18(2):75-7
48. Maruo T. et al.. Production of Choriogonadotropin-like factor by a microorganism. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6622-6
49. McGarvey ME. Tulpule A. et. Al.. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol Sep;10(5):413-21 1998
50. Miller R. et al.. A clinical study of the use of human chorionic gonadotrophin in weight reduction. J Fam Pract. 1977 Mar;4(3):445-8
51. Morgan FJ. et al.. Chemistry of human chorionic gonadotropin. Monograph. 1976 May 25
52. Mueller WH. Relative reliability of circumferences and skinfolds as measures of body fat distribution. Am J Phys Anthropol 1987 Apr;72(4):437-9
53. Niebroj TK. et al.. Effect of chorionic gonadotropins administration on water metabolism in glaucomatous women. Endokrynol Pol. 1971 May-Jun;22(3):251-5
54. Orphanidou C. Accuracy of subcutaneous fat measurement: comparison of skinfold calipers. ultrasound, and computed tomography. J Am Diet Assoc 1994 Aug;94(8):855-8
55. Orphanidou CI, McCargar LJ, Birmingham CL, Belzberg AS.Changes in body composition and fat distribution after short-term weight gain in patients with anorexia nervosa.Am J Clin Nutr. 1997 Apr ; 65 (4) :1034-41.
56. Perniola R. et al.. Human chorionic gonadotrophin therapy in hypogonadal thalassaemic patients with osteopenia: increase in bone mineral density. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:995-6
57. Pickar D et al.. Clinical studies of the endogenous opioid system. Biol Psychiatry 1982 Nov;17(11):1243-76
58. Pierce JG.. Eli Lilly lecture. The subunits of pituitary thyrotropin--their relationship to other glycoproteic hormones. Endocrinology. 1971 Dec;89(6):1331-44
59. Rabe T. et al.. Risk-benefit analysis of a hCG-500 kcal reducing diet (cura romana) in females. Geburtshilfe Frauenheilkd. 1987 May;47(5):297-307
60. Reiss M.. Stunted growth and the mechanism of its stimulation in mentally disturbed adolescents. Int J Neuropsychiatry. 1965 Aug;1(4):313-7
61. Rivlin RS.. Therapy of obesity with hormones. N Engl J Med. 1975 Jan 2;292(1):26-9
62. Ross GT.. Clinical relevance of research on the structure of human chorionic gonadotropin. Am J Obstet Gynecol. 1977 Dec 1;129(7):795-808
63.Sanders S, Norman AP.Chorionic gonadotrophin in male growth-retarded adolescent asthmatic patients.Practitioner. 1973 May;210(259):690-2. 
64. Sarma JM. Houghten RA. Enzyme linked immunosorbent assay (ELISA) for beta-endorphin and its antibodies. Life Sci 1983;33 Suppl 1:129-32
65. Sarria A et al.. Skinfold thickness measurements are better predictors of body fat percentage than body mass index in male Spanish children and adolescents. Eur J Clin Nutr 1998 Aug;52(8):573-6
66. Scaffidi A. Data on the pathogenesis and therapy of bronchial asthma in patients with secondary hypogonadism. Minerva Med Dec 1;65(86):4473-6 1974
67. Segal SJ (ed.). Chorionic Gonadotropin. Plenum Press: NY. 1980
68. Shetty KR. et al.. Human chorionic gonadotropin (HCG) treatment of obesity. Arch Intern Med. 1977 Feb;137(2):151-5
69. Shomer-Ilan A. et al.. Further evidence for the presence of an endogenous gonadotrophin-like plant factor:  "phytotrophin" .Isolation and mechanism of action of the active principle. Aust J Biol Sci. 1973 Feb;26(1):105-12
70. Simeons ATW. The action of chorionic gonadotropin in the obese. Lancet II:1954: 946-947
71. Simeons ATW.. Pounds and Inches: A new approach to obesity. Private Printing (1976)
72. Stein MR. et al.. Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study. Am J Clin Nutr. 1976 Sep;29(9):940-8
73. Stern JS.. Weight control programs. Curr Concepts Nutr. 1977;5:137-55
74. Suginami H. et al.. Immunohistochemical localization of a human chorionic gonadotropin-like substance in the human pituitary gland. J Clin Endocrinol Metab. 1982 Dec;55(6):1161-6
75. Tagliabue A et al.. Application of bioelectric impedance measurement in the evaluation of body fat. Recenti Prog Med 1989 Feb;80(2):59-62
76. Talbot LA et al.. Assessing body composition: the skinfold method. AAOHN J 1995 Dec;43(12):605-13
77. Tavio M. Nasti G. Simonelli C. et. Al.. Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma. Eur J Cancer Sep;34(10):1634-7 1998
78. Torgerson JS et al.. VLCD plus dietary and behavioral support versus support alone in the treatment of severe obesity. A randomised two-year clinical trial. Int J Obes Relat Metab Disord 1997 Nov;21(11):987-94
79. Vaitukaitis JL.. Glycoprotein hormones and their subunits--immunological and biological characterization. Monograph. 1979 May 23
80. Veilleux H. et al.. Gonadic and extragonadic effects in humans of 3.500 I.U. of HCG (human chorionic gonadotropin) in fractional doses. Vie Med Can Fr. 1972 Sep;1(9):862-71
80b.Vogt T, Belluscio D.Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment. Aesthetic Plast Surg. 1987;11(3):131-56. Review.
81. Wattanapenpaiboon N. et al.. Agreement of skinfold measurement and bioelectrical impedance analysis (BIA) methods with dual energy X-ray absorptiometry (DEXA) in estimating total body fat in Anglo-Celtic Australians. Int J Obes Relat Metab Disord. 1998 Sep;22(9):854-60
82. Weits T. et al.. Comparison of ultrasound and skinfold caliper measurement of subcutaneous fat tissue. Int J Obes 1986;10(3):161-8
83. Yanagihara Y. Carbohydrate and lipid metabolism in pregnant albino rats during hunger after loading with gonad-stimulating hormones. Nippon Sanka Fujinka Gakkai Zasshi 1966 Nov;18(11):1293-301
84. Yanagihara Y. Carbohydrate and fatty acid metabolism in pregnant albino rats simultaneously loaded with fat emulsion and sex stimulating hormones during starvation. Nippon Sanka Fujinka Gakkai Zasshi 1967 Jan;19(1):8-14
85. Yanagihara Y. Carbohydrate and lipid metabolism in pregnant albino rats during starvation after loading with gonad-stimulating hormones. Nippon Sanka Fujinka Gakkai Zasshi 1966 Dec;18(12):1379-84
86. Yoshimoto Y. et al.. Human chorionic gonadotropin--like material: presence in normal human tissues. Am J Obstet Gynecol. 1979 Aug 1;134(7):729-33
87. Yoshimoto Y. et al.. Human chorionic gonadotropin-like substance in nonendocrine tissues of normal subjects. Science. 1977 Aug 5;197(4303):575-7
88. Young RL. et al.. Chorionic gonadotropin in weight control. A double-blind crossover study. JAMA. 1976 Nov 29;236(22):2495-7
89. Zakut H. et al.. hCG as tumor marker in non-trophoblastic neoplasms. Harefuah. 1985 Jan 15;108(2):82-5
90. Zondek B. Sulman F. The mechanism of action and metabolism of gonadotrophic hormones in the organism. Vit Horm 1945 3:297-336

 


Tiene el placer de anunciar la apertura a inscripción para el 2º Simposio Internacional Anual y Programa de Entrenamiento sobre el uso de hCG para el Tratamiento de la Obesidad y Morbilidades Asociadas. Click aquí..

 

Nuestro nuevo sitio completamente actualizado sobre el uso de la Gonadotrofina Coriónica
para el tratamiento de la obesidad

http://oralhcg.com

Nuestro sitio anterior

Investigación y capacitación en el método de hCG (Gonadotrofina Coriónica) oral para el tratamiento de la obesidad y el sobrepeso


Condiciones de Uso

  Inicio | Autorizaciones | Biblioteca | Búsqueda en Indexmedico | Artículos interesantes para profesionales | AyudaContenido para profesionales| Ediciones para profesionales | Ediciones para el público | Foro de discusión | Hospitales de Iberoamérica | Indexmedico JournalAcerca de Indexmedico  | Inscripción - Profesionales | Inscripción - Público | Journals | Medline | Opinión - Profesionales Opinión - Público | Publicidad |  RevistasServicios de Contenido | Sobrepeso |

Para consultas y comentarios


Copyright © 1994-2007 Indexmedico e InterSol, Inc. - Todos los derechos reservados.
Revisado:01/07/2008